F Graziani1, A Pujol1, C Nicoletti1, S Dou2, M Maresca1, T Giardina1, M Fons3, J Perrier1. 1. iSm2 UMR 7313, CNRS, Centrale Marseille, Aix Marseille Université, Marseille, France. 2. UP 2012.10.120.EGEAL, Institut Polytechnique, La Salle Beauvais, France. 3. IMM UMR 7283, CNRS, Aix Marseille Université, Marseille, France.
Abstract
AIMS: The molecular cross-talk between commensal bacteria and the gut play an important role in the maintenance of the intestinal homeostasis and general health. Here, we studied the impact of a major Gram-positive anaerobic bacterium of the human gut microbiota, that is, Ruminococcus gnavus on the glycosylation pattern and the production of intestinal mucus by the goblet cells. METHODS AND RESULTS: Our results showed that R. gnavus E1 specifically increases the expression and the glycosylation level of the intestinal glyco-conjugates by goblet cells in the colonic mucosa of mono-associated mice with R. gnavus E1 as well as in human HT29-MTX cells. Such an effect was mediated through induction of the level of mRNA encoding for the major intestinal gel-forming mucin such as MUC2 and various glycosyltransferase enzymes. CONCLUSIONS: This study demonstrates for the first time that R. gnavus E1 possess the ability to modulate the glycosylation profile of the glyco-conjugate molecules and mucus in goblet cells. SIGNIFICANCE AND IMPACT OF THE STUDY: Furthermore, we demonstrated that R. gnavus E1 modified specifically the glycosylation pattern and MUC2 expression by means of a small soluble factor of peptidic nature (<3 kDa) and heat stable in the HT29-MTX cell.
AIMS: The molecular cross-talk between commensal bacteria and the gut play an important role in the maintenance of the intestinal homeostasis and general health. Here, we studied the impact of a major Gram-positive anaerobic bacterium of the human gut microbiota, that is, Ruminococcus gnavus on the glycosylation pattern and the production of intestinal mucus by the goblet cells. METHODS AND RESULTS: Our results showed that R. gnavus E1 specifically increases the expression and the glycosylation level of the intestinal glyco-conjugates by goblet cells in the colonic mucosa of mono-associated mice with R. gnavus E1 as well as in human HT29-MTX cells. Such an effect was mediated through induction of the level of mRNA encoding for the major intestinal gel-forming mucin such as MUC2 and various glycosyltransferase enzymes. CONCLUSIONS: This study demonstrates for the first time that R. gnavus E1 possess the ability to modulate the glycosylation profile of the glyco-conjugate molecules and mucus in goblet cells. SIGNIFICANCE AND IMPACT OF THE STUDY: Furthermore, we demonstrated that R. gnavus E1 modified specifically the glycosylation pattern and MUC2 expression by means of a small soluble factor of peptidic nature (<3 kDa) and heat stable in the HT29-MTX cell.
Authors: Matthew R Kudelka; Sean R Stowell; Richard D Cummings; Andrew S Neish Journal: Nat Rev Gastroenterol Hepatol Date: 2020-07-24 Impact factor: 46.802
Authors: Joannie M Allaire; Vijay Morampudi; Shauna M Crowley; Martin Stahl; Hongbing Yu; Kirandeep Bhullar; Leigh A Knodler; Brian Bressler; Kevan Jacobson; Bruce A Vallance Journal: Am J Physiol Gastrointest Liver Physiol Date: 2017-11-09 Impact factor: 4.052
Authors: Alfredo Perales-Puchalt; Jairo Perez-Sanz; Kyle K Payne; Nikolaos Svoronos; Michael J Allegrezza; Ricardo A Chaurio; Carmen Anadon; Joseph Calmette; Subir Biswas; Jessica A Mine; Tara Lee Costich; Logan Nickels; Jayamanna Wickramasinghe; Melanie R Rutkowski; Jose R Conejo-Garcia Journal: J Leukoc Biol Date: 2018-03-14 Impact factor: 4.962